Market Rebound, Facebook COO & Regeneron Chief Scientific Officer

Mad Money w/ Jim Cramer

CNBC

News, Investing, Business

4.3 • 4K Ratings

🗓️ 17 March 2020

⏱️ 45 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

After a day where the Dow fell nearly 3,000 points, Jim Cramer's breaking down what today's 1,000+ point bounce could mean for the future. Then, Facebook announced today that it's pledging $100 million to support small businesses that are impacted by COVID-19, and Cramer's checking in with the company's COO, Sheryl Sandberg, to discuss the initiative. Plus, Regeneron announced today that it's ahead of schedule on creating a COVID-19 treatment, and Cramer's checking in with the company's Chief Scientific Officer to get more details on the latest developments.

Transcript

Click on a timestamp to play from that location

0:00.0	My mission is simple to make you money.
0:04.0	I'm here to level the playing field for all investors.
0:07.0	There's always a more work at Summer,
0:09.0	and I promise to help you find it.
0:11.0	Man money starts now.
0:20.0	Hey, I'm Kramer.
0:21.0	Welcome to Man Money.
0:22.0	Welcome to Kramer, Erica.
0:23.0	Before we start, let's go to Steve Least,
0:25.0	and do us some breaking news.
0:31.0	Hello?
0:33.0	Steve, it's Jim.
0:34.0	You've got me. You're alive.
0:39.0	The Federal Reserve announcing yet another program,
0:42.0	the primary dealer credit facility.
0:44.0	This is one of the biggest programs the Federal Reserve has yet to do.
0:47.0	It is called the Kitchen Sync of Lending Programs.
0:51.0	It provides short term, overnight, and term funding up to 90 days
0:55.0	for a very broad range of assets.
0:59.0	I can tell you the kinds of assets that now primary dealers
1:02.0	can bring to the Fed to get funding,
1:04.0	investment grade corporate debt securities,
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.